Third Seven Capital

Four Springs Capital Trust is a private real estate investment firm based in Lake Como, New Jersey, established in 2012. The company specializes in acquiring and managing a diversified portfolio of single-tenant net lease properties, focusing on sectors such as industrial, medical, retail, and office spaces. It targets high-quality tenants and seeks properties with remaining lease terms exceeding ten years, which include contractual rent increases. By actively managing its portfolio, Four Springs Capital Trust aims to provide a stable and diversified tenant base, catering to the income-producing commercial real estate market across the United States.

Vinci Pharmaceuticals is a healthcare company focused on developing treatments for retinal diseases, particularly in patients suffering from intermediate-stage conditions. The company utilizes a proprietary platform featuring implant technology that delivers drugs directly to targeted tissues in the retina. This approach aims to provide safe, durable, and minimally invasive solutions to prevent blindness and improve patients' vision. By concentrating on therapies for these specific retinal diseases, Vinci Pharmaceuticals addresses a critical need in ophthalmology, enhancing the prospects for those affected by such conditions.

Newlight Technologies, Inc. specializes in greenhouse gas-to-plastic bioconversion technology, enabling the production of high-performance thermoplastics from air and methane emissions. The company's flagship product, AirCarbon, is derived from sequestered carbon emissions and serves as a sustainable alternative to traditional fossil fuel-based plastics such as polypropylene, polyethylene, ABS, polystyrene, and TPU. Founded in 2003 and headquartered in Huntington Beach, California, Newlight Technologies is committed to decarbonization and aims to replace oil-based plastics with AirCarbon on a global scale. By utilizing carbon that would otherwise contribute to atmospheric pollution, the company seeks to reduce overall carbon levels while promoting environmentally friendly materials in various applications.

UDIS Capital Partners LLC, established in 2016 and located in New York, offers specialized investment management consultancy services. The firm focuses on business development for investment management companies seeking growth opportunities. UDIS Capital Partners excels in facilitating the introduction of both foreign and domestic capital, managing cross-border transactions, and providing foreign currency solutions. By enhancing deal flow between investors and investment professionals, the company supports its clients in navigating the complexities of international and domestic markets.

Wunderkind, Inc. is a technology company that specializes in cloud-based solutions for customer acquisition and behavioral marketing automation. Founded in 2010 and headquartered in New York City, with an additional office in London, Wunderkind offers a platform known as BounceX, which focuses on people-based marketing. This platform enables online publishers and retail website owners to engage visitors through targeted messaging and timely advertising, ultimately enhancing conversion rates and increasing revenue. Wunderkind's technology leverages real-time user behavior data, such as mouse movements and intent signals, to identify potential customers and deliver personalized experiences across various channels, including websites, email, and advertisements. The company's impressive client roster includes well-known brands like Uniqlo, Lufthansa, and CNN, and it is recognized for driving significant revenue growth for these businesses through its innovative marketing solutions.

Steele Creek has an investment objective to generate current income by investing primarily in fixed-income instruments, including broadly syndicated bank loans, structured products, mezzanine financings, and secured bonds. It is a business development company that invests in bank loans and structured products.

EhmetDX is commercializing the latest advancements in medical device technology to address identifiable needs within the healthcare market. The company's patented technology allows the practitioner to deliver whole or partial breast irradiation while minimizing exposure to critical structures at risks such as lung, heart, and skin, and lowering the whole-body dose to the patient. By offering these advantages, clinicians can apply novel approaches such as accelerated radiation treatment to reduce procedure time as well as allowing for advanced techniques such as stereotactic radiation therapy.

Fund That Flip, Inc. operates an online investment platform focused on short-term residential real estate redevelopment projects. Founded in 2014 and headquartered in New York, with additional offices in Cleveland, the company sources and underwrites various redevelopment initiatives, allowing accredited investors to invest in borrower-dependent notes associated with each project. Fund That Flip provides short-term loans to real estate redevelopers who acquire and renovate residential properties, ultimately aiming to restore communities across the United States. The platform connects experienced redevelopers with a diverse base of institutional and individual investors, facilitating passive wealth generation in the residential rehab loan market. The company has been recognized for its rapid growth, ranking on the 2019 Inc. 500 list of the fastest-growing private companies in the nation.

HFactor is a beverage company based in Bryn Mawr, Pennsylvania, specializing in hydrogen-infused water that is rich in antioxidants. As a pioneer in the functional beverage sector, HFactor provides a unique product aimed at enhancing health and wellness. The company focuses on environmentally friendly practices, utilizing an ergonomic and sustainable packaging design for its hydrogen water. In addition to its core beverage business, HFactor operates a wholly-owned subsidiary that is involved in the development and leasing of facilities for marijuana growers and dispensary owners. Through its innovative approach and commitment to quality, HFactor aims to contribute positively to both consumer health and environmental sustainability.

Armis Biopharma, Inc. is a biopharmaceutical company focused on developing and commercializing late-stage clinical products and antimicrobial therapies. Based in Fort Collins, Colorado, the company specializes in non-systemic anti-infective therapeutics aimed at combatting antibiotic resistance and healthcare-associated infections. Its product offerings include Ximycin, a patented localized antimicrobial therapy that provides broad-spectrum coverage against polymicrobial infections at surgical sites, and Veriox, a proprietary platform utilizing peracid technology to treat infections while also promoting positive tissue effects. Armis Biopharma serves various markets, including wound care, orthopedics, and dermatology, and addresses the growing challenges posed by resistant pathogens and chemical/biological threats. The company was incorporated in 1997 and continues to expand its innovative pipeline to meet critical healthcare needs.